ClinConnect ClinConnect Logo
Search / Trial NCT04757350

Objective Visual Quality Analysis System is Used in Cataract

Launched by WUHAN UNION HOSPITAL, CHINA · Feb 13, 2021

Trial Information

Current as of June 26, 2025

Unknown status

Keywords

Cataract

ClinConnect Summary

The Objective Visual Quality Analysis System (OQAS) is a new inspection technology used to objectively assess the visual quality of the human eye. It can detect the impact of ocular refractive system diseases on the objective visual quality of patients. It is currently mainly used to assess the progress of cataracts and help selection the timing of surgery has achieved good clinical results. Before the emergence of OQAS, the rating of cataracts largely relied on the subjective experience of physicians, and OQAS could accurately assess the effects of cataracts on the visual quality of the hu...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Cataract patients aged 18-90 or patients after cataract surgery;
  • 2. Signed and dated informed consent;
  • 3. Commit to abide by the research procedures and cooperate with the implementation of the whole process research
  • Exclusion Criteria:
  • 1. Obvious conjunctivitis;
  • 2. Obvious corneal epithelial punctate staining, corneal epithelial shedding;
  • 3. Keratitis;
  • 4. Uveitis;
  • 5. Corneal scar;
  • 6. Severe vitreous opacity or hemorrhage;
  • 7. Other situations deemed unsuitable for inclusion in this study after evaluation by ophthalmologists.

About Wuhan Union Hospital, China

Wuhan Union Hospital, affiliated with Huazhong University of Science and Technology, is a leading medical institution located in Wuhan, China. Renowned for its comprehensive healthcare services and advanced research capabilities, the hospital plays a pivotal role in clinical trials aimed at enhancing medical knowledge and patient care. With a commitment to innovation and excellence, Wuhan Union Hospital collaborates with various stakeholders to conduct rigorous and ethically sound clinical research, contributing significantly to the advancement of medical science and public health both domestically and internationally.

Locations

Wuhan, Hubei, China

Patients applied

0 patients applied

Trial Officials

yukan huang, professor

Study Chair

Wuhan Union Hospital, China

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials